SBI Securities
OPHI icon

SBI Securities’s CollPlant Biotechnologies OPHI Stock Holding History

SBI Securities’s Portfolio OPHI Stock Details OPHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$76 Hold
20
– – ﹤0.01% 3651
2026
Q2 		$70 Hold
20
– – ﹤0.01% 3594
2026
Q1 		$107 Hold
20
– – ﹤0.01% 3387
2025
Q4 		$280 Hold
20
– – ﹤0.01% 3098
2025
Q3 		$541 Hold
20
– – ﹤0.01% 2935
2025
Q2 		$272 Hold
20
– – ﹤0.01% 3215
2025
Q1 		$516 Hold
20
– – ﹤0.01% 2863
2024
Q4 		$720 Buy
+20
New +$813 ﹤0.01% 2752

Other funds holding OPHI

St. Denis J. Villere & Co
St. Denis J. Villere & Co New Orleans, Louisiana $775M AUM 13.27% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Parkside Financial Bank & Trust
Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return
Strive Financial Group
Strive Financial Group Carmel, Indiana $316M AUM 17.91% 1-Year Est. Return

SBI Securities's OPHI Position: Q3 2026 in Review

SBI Securities held its CollPlant Biotechnologies (OPHI) position steady in Q3 2026 at 20 shares worth $76. The position accounts for ﹤0.01% of the portfolio, ranked #3651.

SBI Securities first reported a position in OPHI in Q4 2024 and has held it in 8 quarters since. The position peaked at $720 in Q4 2024. 7 funds tracked by Wall St. Rank hold OPHI as of Q3 2026.

  • SBI Securities held 20 shares of CollPlant Biotechnologies worth $76 as of Q3 2026.
  • SBI Securities left its CollPlant Biotechnologies share count unchanged in Q3 2026.
  • CollPlant Biotechnologies made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3651 holding.
  • SBI Securities first reported a position in CollPlant Biotechnologies in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's CollPlant Biotechnologies position peaked at $720 in Q4 2024.
  • 7 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.